Next year, average enrollee premium payments in the FEHB system are set to jump more than 12%, on top of a 13.5% hike in 2025.

AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) was approved in the U.S. for the treatment of adult ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

U.S. set to unveil 15 new Medicare-negotiated drug prices; U.S.-U.K. drug pricing deal could be unveiled; Louisiana surgeon general tapped as deputy director at CDC.

Fighting invasive oral cancer at age 51 forced Sonya Sotinsky to confront the existential importance of the human voice.

Officials have deemed terms like “immunizations” and “vaccines” risky “buzzwords” that require approval to be used in social media posts, pamphlets and presentations.

The FDA issued a letter to Incyte on November 20 indicating that the drugmaker addressed the violations contained in an Untitled Letter it received in September.

During the incipient days of computing, DOS, or Disk Operating System, did more than just power the machines; it defined how the machines worked. It was the essential, unifying language that allowed ...

Biopharmaceutical company Gilead Sciences has hired Bob Allen as head of omnichannel strategy and digital transformation for public affairs.